TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
FHTX

Foghorn Therapeutics Inc

Healthcare · Biotechnology

2.00$ -30.8% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FHTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
93.8% 75.6% 74.6% 88.4% 86.8% 84.0% 87.9% 82.4%
92.9% 67.1% 36.3% 19.5% 12.9% 28.1% 19.5% 40.8%
92.9% 67.1% 72.7% 29.7% 85.4% 81.9% 85.8% 80.2%
– – 0.3% 57.7% 0.6% – – –
– – – -67.9% – – – –
4.9% 16.6% 24.4% 10.8% 12.2% – – –
191.2% 493.9% 42.8% 81.4% 100.0% 127.0% 116.0% 154.8%
8.0% 56.6% 7.4% 9.4% 13.6% 20.4% 23.6% 30.2%
– 24.7% 1.6% 1.3% 1.5% 3.0% 3.2% 0.5%
4.7% 15.4% 1.4% 0.7% 1.3% 2.2% 1.3% 2.2%
16.3% 49.1% 7.7% – – – – –
-91.2% -393.9% 57.2% 18.6% 0.0% -27.0% -16.0% -54.8%
-99.9% -421.3% -63.7% -50.8% -92.2% -164.9% -196.6% -319.3%
45.6% 164.8% 14.4% 7.2% 10.3% 14.7% 19.3% 31.8%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?